Commonly Prescribed Medications Among Patients in Hospice Care for Chronic Obstructive Pulmonary Disease.
Am J Hosp Palliat Care. 2016 Aug;33(7):638-43
Authors: Afrane M, Sera L, Holmes HM, McPherson ML
PURPOSE: End-stage chronic obstructive pulmonary disease (COPD) presents health care providers with challenges of providing optimal palliative care for patients who follow a less predictable trajectory. The objectives of this study were to evaluate medications being prescribed to patients with end-stage COPD, compared to recommendations made by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, and to determine which medications were provided by the hospice organization.
METHODS: We retrospectively reviewed our database for medications pertaining to COPD management as stated in the GOLD criteria or those used for symptoms associated with end of life.
RESULTS: A total of 745 patients met inclusion criteria, and approximately 63% were prescribed opioids. Prescribing rates for oxygen, short-acting β2-agonists, and short-acting anticholinergics were 37%, 33%, and 31%, respectively. Systemic and inhaled corticosteroids were prescribed at higher rates of 20% and 18% compared to long-acting bronchodilators.
DISCUSSION: Medications used for COPD exacerbation management were prescribed at higher rate than those used for maintenance treatment.
PMID: 26261375 [PubMed - indexed for MEDLINE]